St. Johns Investment Management’s AstraZeneca AZN Stock Holding History

St. Johns Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.5K	Hold	29	–	–	﹤0.01%	147
2026 Q1	$5.72K	Hold	29	–	–	﹤0.01%	141
2025 Q4	$5.33K	Hold	29	–	–	﹤0.01%	142
2025 Q3	$4.45K	Hold	29	–	–	﹤0.01%	152
2025 Q2	$4.05K	Hold	29	–	–	﹤0.01%	150
2025 Q1	$4.26K	Hold	29	–	–	﹤0.01%	140
2024 Q4	$3.8K	Hold	29	–	–	﹤0.01%	147
2024 Q3	$4.52K	Hold	29	–	–	﹤0.01%	162
2024 Q2	$4.52K	Hold	29	–	–	﹤0.01%	145
2024 Q1	$3.93K	Buy	+29	New	+$3.84K	﹤0.01%	160

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

St. Johns Investment Management's AZN Position: Q2 2026 in Review

St. Johns Investment Management held its AstraZeneca (AZN) position steady in Q2 2026 at 29 shares worth $5.5K. The position accounts for ﹤0.01% of the portfolio, ranked #147.

St. Johns Investment Management first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.72K in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

St. Johns Investment Management held 29 shares of AstraZeneca worth $5.5K as of Q2 2026.
St. Johns Investment Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up ﹤0.01% of St. Johns Investment Management's portfolio in Q2 2026, its #147 holding.
St. Johns Investment Management first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
St. Johns Investment Management's AstraZeneca position peaked at $5.72K in Q1 2026.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on St. Johns Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.